None listed
Conditions
Interventions
Medical Device : Insertion of metal stent (single metal stent with a cover and a double metal stent without a cover.) for malignant biliary tract obstruction through ERCP, The stent patency was compar
Sponsors
Yonsei University Health System, Gangnam Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A patient whose malignant tumor invading the biliary tract was confirmed histologically or radiographically, or who had clinical obstruction symptoms and radiographic findings related to malignant tumor-related biliary obstruction and proximal bile duct dilatation. (the range of lesions is for pancreatic cancer, biliary tract cancer, gallbladder cancer, papillary cancer, liver cancer, gastrointestinal cancer that can cause biliary tract obstruction, and metastatic lymph nodes)
Exclusion criteria
Exclusion criteria: 1. Resectable bile duct cancer 2. Malignant hilar biliary obstruction 3. Duodenal obstruction 4. Patients with other malignancies other than malignant tumors that invaded the biliary tract 5. Patients with uncontrolled serious infection 6. Patients who failed to obtain informed consent from the patient 7. Patients who are technically unable to perform endoscopic procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean patency duration | — |
Secondary
| Measure | Time frame |
|---|---|
| 6-months patency rate | — |
Countries
Korea, Republic of
Contacts
Public ContactSung Yong Han
Pusan National University Hospital
Outcome results
None listed